PerkinElmer seals multiplex testing deal with Luminex :
This article was originally published in Clinica
Wellesley, Massachusetts-based PerkinElmer has linked up with Luminex to develop technology for high-volume disease screening. It has licensed the Austin, Texas firm's xMAP multiplex testing know-how - which can perform multiple biomedical tests on a single sample - for use in the development of in vitro diagnostics in maternal, neonatal and prenatal health as well as for use in several areas of life science research. PerkinElmer also plans to standardise its multiplex assay development on the Luminex xMAP platform.